We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10.9B
AUM Growth
+$843M
(+8.4%)
Cap. Flow
+$426M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
1,453
New
18
Increased
663
Reduced
669
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$32.9M |
| 2 |
Microsoft
MSFT
|
+$24.3M |
| 3 |
Amazon
AMZN
|
+$21.5M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17.4M |
| 5 |
DuPont de Nemours
DD
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$16.3M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$13.1M |
| 3 |
A.O. Smith
AOS
|
+$9.9M |
| 4 |
S&P Global
SPGI
|
+$8.24M |
| 5 |
AbbVie
ABBV
|
+$6.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.75% |
| 2 | Financials | 14.74% |
| 3 | Technology | 14.3% |
| 4 | Consumer Staples | 10.87% |
| 5 | Industrials | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Regenxbio
RGNX
$613M
| $636K | 0.01% |
19,293
+1,041
| +6% | +$23.4K |
|
877
Curtiss-Wright
CW
$27.6B
| $634K | 0.01% |
6,069
-1,141
| -16% | -$111K |
|
878
PTC
PTC
$13.6B
| $633K | 0.01% |
11,241
-961
| -8% | -$53.2K |
|
879
Core Laboratories
CLB
$551M
| $632K | 0.01% |
6,402
+2,513
| +65% | +$244K |
|
|
ARNA
880
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $632K | 0.01% |
24,793
+5,668
| +30% | +$130K |
|
881
Avient
AVNT
$3.42B
| $630K | 0.01% |
15,734
-2,281
| -13% | -$85.1K |
|
|
MASI
882
DELISTED
Masimo
MASI
| $629K | 0.01% |
7,265
+156
| +2% | +$13.8K |
|
883
Transocean
RIG
$5.91B
| $629K | 0.01% |
58,448
-7,340
| -11% | -$63.2K |
|
884
Assured Guaranty
AGO
$3.8B
| $624K | 0.01% |
16,519
-1,039
| -6% | -$44.5K |
|
885
Editas Medicine
EDIT
$399M
| $619K | 0.01% |
25,767
+1,556
| +6% | +$29.6K |
|
|
CXP
886
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $619K | 0.01% |
28,442
-4,306
| -13% | -$92.7K |
|
|
ABMD
887
DELISTED
Abiomed Inc
ABMD
| $618K | 0.01% |
3,668
-7
| -0.2% | -$1.06K |
|
888
TD Synnex
SNX
$19.7B
| $616K | 0.01% |
9,742
-1,636
| -14% | -$96.5K |
|
889
Littelfuse
LFUS
$10.3B
| $605K | 0.01% |
3,091
-575
| -16% | -$104K |
|
890
Trustmark
TRMK
$2.74B
| $604K | 0.01% |
18,248
-3,384
| -16% | -$105K |
|
891
Travere Therapeutics
TVTX
$5.28B
| $604K | 0.01% |
24,249
+1,277
| +6% | +$28.1K |
|
892
Robert Half
RHI
$3.6B
| $598K | 0.01% |
11,875
+1,523
| +15% | +$70.4K |
|
|
TCF
893
DELISTED
TCF Financial Corporation
TCF
| $590K | 0.01% |
34,650
-8,098
| -19% | -$128K |
|
894
Ingredion
INGR
$6.37B
| $588K | 0.01% |
4,872
-434
| -8% | -$52.9K |
|
895
Tyler Technologies
TYL
$12.3B
| $588K | 0.01% |
3,373
-188
| -5% | -$32.3K |
|
896
International Bancshares
IBOC
$4.78B
| $587K | 0.01% |
14,647
-3,252
| -18% | -$118K |
|
897
Valvoline
VVV
$4.94B
| $584K | 0.01% |
24,897
+10,760
| +76% | +$242K |
|
898
Akebia Therapeutics
AKBA
$325M
| $583K | 0.01% |
29,632
+6,424
| +28% | +$98.8K |
|
899
Ziff Davis
ZD
$1.94B
| $583K | 0.01% |
9,078
-1,496
| -14% | -$101K |
|
900
Invesco Mortgage Capital
IVR
$784M
| $582K | 0.01% |
3,395
-588
| -15% | -$99.1K |
|
Similar funds
ProShare Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, ProShare Advisors held 1,453 positions worth $10.9B, up 8.4% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors deployed $426M of net new capital in Q3 2017, opening 18 new positions and adding to 663 existing holdings. Its largest new stake was Baker Hughes: 116,604 shares worth $4.27M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was CR Bard Inc., an estimated $13.1M trimmed.
- ProShare Advisors's largest Q3 2017 buy was Baker Hughes: 116,604 shares worth $4.27M.
- ProShare Advisors added most to Apple in Q3 2017, an estimated $32.9M increase.
- ProShare Advisors's biggest Q3 2017 reduction was CR Bard Inc., cutting an estimated $13.1M.
- ProShare Advisors fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $16.3M.
- ProShare Advisors's ten largest holdings make up 16% of its $10.9B portfolio in Q3 2017.
- ProShare Advisors opened 18 new positions and closed 101 in Q3 2017.
- ProShare Advisors's portfolio value rose 8.4% quarter-over-quarter to $10.9B.
Based on ProShare Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.